New RNA drug ORN252 tested in humans for first time
Knowledge-focused
Recruiting now
This early-phase study is testing a new experimental drug called ORN252 in 20 healthy adults. ORN252 is a type of RNA therapy wrapped in a fat particle, designed to help the body make a protein that targets certain immune cells. The main goal is to check if it is safe and how the…
Phase: PHASE1 • Sponsor: Orna Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC